IntelliGenome, Inc., a biotechnology company developing CRISPR-based molecular diagnostics, today announced the appointment of ILEX South Africa (Pty) Ltd. as its exclusive distributor for CRISPR-TB® ...

Changchun Liu, professor of Biomedical Engineering at UConn Health, has developed a new method that improves existing diagnostic technology for a more rapid, sensitive, and deployable approach to ...

Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...

BRISBANE, Calif.--(BUSINESS WIRE)--Mammoth Biosciences, the biotech company leveraging the diversity of life to build the next generation of CRISPR products to cure and detect disease, today announced ...

A study aiming to develop a low-cost, rapid detection technique for the widescale detection and screening of oral microorganisms suitable for point-of-care settings was presented at the 102nd General ...

Bioengineering professor and The Grainger College of Engineering's Dean, Rashid Bashir, led a team of researchers in a project that's resulted in new technology that offers rapid, highly sensitive ...

IntelliGenome, Inc., a leader in CRISPR-based molecular diagnostics, today announced the appointment of Yu Shing Bio-Tech Co., Ltd. as its exclusive distributor for Taiwan. Under the agreement, Yu ...

The CRISPR/Cas system, known for gene editing, is now revolutionizing molecular diagnostics due to its high specificity and efficiency in recognizing and cleaving target sequences. Cas9, Cas12, and ...

Researchers have developed a fast, specific and reliable test for mpox infection, combining CRISPR/Cas12a and nanopore sensing. Research presented at the 68th Biophysical Society Annual Meeting (10-14 ...

Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and residents of nursing homes, especially those who are already weakened by ...

Smartphone-based optical imaging and sensing devices are among the next-generation biosensors that have shown great potential to transform the field of point-of-care (POC) diagnostics. With the rapid ...